March 7 (Reuters) - Helix Biopharma Corp HBP.TO
* Announces strategic management changes
* Dr. Sven Rohmann, CEO and chairman of company, will be stepping down from his position as chief executive officer
* Heman Chao will assume position of chief executive officer Source text for Eikon: ID:nMKWzb02ba Further company coverage: HBP.TO
(Bangalore.newsroom@thomsonreuters.com)